Kasha Singh

COVID-19 pandemic 2020: a tertiary Melbourne hospital's experience

Brodie Farrow, Asha Bonney, Kasha P Singh, Steven Tong, Louis Irving, Wen Kwang Lim, Seok Lim, Douglas Johnson, Caroline Marshall, Kirsty Buising, Belinda Liu, Benjamin Cowie, Megan Rees, Alistair Miller

Journal article  |  2022  |  INTERNAL MEDICINE JOURNAL

BACKGROUND: The COVID-19 pandemic has affected different parts of Australia in distinct ways across 2020 and 2021. In 2020, Melbou..

Diabetes mellitus, glycaemic control, and severe COVID-19 in the Australian critical care setting: A nested cohort study.

Mark P Plummer, Louise Rait, Mark E Finnis, Craig J French, Samantha Bates, James Douglas, Mansi Bhurani, Tessa Broadley, Tony Trapani, Adam M Deane, Andrew A Udy, Aidan JC Burrell, undefined SPRINT-SARI Australia Investigators

Journal article  |  2022  |  Aust Crit Care

BACKGROUND: Internationally, diabetes mellitus is recognised as a risk factor for severe COVID-19. The relationship between diabet..

Risk factors for surgical site infection in free-flap reconstructive surgery for head and neck cancer: Retrospective Australian cohort study.

Peter Francis Gearing, John Frederick Daly, Nicholas Shi Jie Tang, Kasha Singh, Anand Ramakrishnan

Journal article  |  2021  |  Head Neck

BACKGROUND: Surgical site infections (SSI) are common complications of free-flap reconstruction for head and neck cancer defects. ..

Therapeutics for COVID-19: established and in development

Kasha P Singh, Joe Sasadeusz, Sharon R Lewin, Jennifer Audsley

Journal article  |  2021  |  MICROBIOLOGY AUSTRALIA

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first recognised in late 2019, with over 30 0..

Rapid Translation of COVID-19 Preprint Data into Critical Care Practice

Aidan JC Burrell, Ary Serpa Neto, Tony Trapani, Tessa Broadley, Craig French, Andrew A Udy

Journal article  |  2021  |  AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Acute kidney injury secondary to severe delayed haemolysis in intravenous artesunate use for severe malaria

Kai Wen Leong, Kasha P Singh, Karin Leder, Steven YC Tong

Journal article  |  2021  |  BMJ CASE REPORTS

The use of artemisinin derivatives has been recommended by the WHO guidelines in malaria treatment largely due to its rapid parasi..

Corrigendum to: Therapeutics for COVID-19: established and in development

Kasha P Singh, Joe Sasadeusz, Sharon R Lewin, Jennifer Audsley

Journal article  |  2021  |  Microbiology Australia

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first recognised in late 2019, with over 30 0..

Hepatitis B Infection in People Living With Human Immunodeficiency Virus: A Global Challenge Needing More Research

Kasha P Singh, Sharon R Lewin

Journal article  |  2020  |  CLINICAL INFECTIOUS DISEASES

Perspectives of Vietnamese, Sudanese and South Sudanese immigrants on targeting migrant communities for latent tuberculosis screening and treatment in low-incidence settings: A report on two Victorian community panels

Chris Degeling, Stacy M Carter, Katie Dale, Kasha Singh, Krista Watts, Julie Hall, Justin Denholm

Journal article  |  2020  |  HEALTH EXPECTATIONS

BACKGROUND: Tuberculosis (TB) elimination strategies in Australia require a focus on groups who are at highest risk of TB infectio..

Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection

Kasha P Singh, Jennifer M Zerbato, Wei Zhao, Sabine Braat, Claire Deleage, G Surekha Tennakoon, Hugh Mason, Ashanti Dantanarayana, Ajantha Rhodes, Jake W Rhodes, Joe Torresi, Andrew N Harman, Peter A Revill, Megan Crane, Jacob D Estes, Anchalee Avihingsanon, Sharon R Lewin, Jennifer Audsley

Journal article  |  2020  |  PLOS PATHOGENS

In HIV-hepatitis B virus (HBV) co-infection, adverse liver outcomes including liver fibrosis occur at higher frequency than in HBV..